Biotech · Private company
Akesobio Australia Pty Ltd
Track this companyFree. Adds Akesobio Australia Pty Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- AK120Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal CancerPHASE2 · RECRUITING · started Jul 28, 2025ClinicalTrials.gov NCT06959550 · fetched Nov 12, 2026
- Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisPHASE2 · TERMINATED · started Sep 30, 2021ClinicalTrials.gov NCT05048056 · fetched Nov 12, 2026
- A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical CancerPHASE2 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04380805 · fetched Nov 12, 2026